2. Gene
  3. C5 - complement C5 Gene

C5 - complement C5 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Rattus norvegicus

Also known as Hc; C5a; RGD1561905

Gene ID: 362119 | Gene type: protein coding

About C5

Summary

Enables C5a anaphylatoxin chemotactic receptor binding activity. Involved in several processes, including glucose homeostasis; leukocyte migration involved in inflammatory response; and negative regulation of Catecholamine secretion. Located in extracellular space. Used to study adult respiratory distress syndrome; asthma; and neutropenia. Biomarker of brain edema. Human ortholog(s) of this gene implicated in several diseases, including Complement Component 5 deficiency; liver cirrhosis; neutropenia; paroxysmal nocturnal hemoglobinuria; and pneumonia. Orthologous to human C5 (complement C5). [provided by Alliance of Genome Resources, Apr 2022]

C5 Products(1)

mRNA Protein Name
NM_053020.1 NP_444179.1 complement C5 precursor
Gene Ontology
  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence Reference Source
enables C5a anaphylatoxin chemotactic receptor binding IDA
IDA: Inferred from direct assay
7987212 RGD
Biological Process GO Annotation Evidence Reference Source
involved in chemotaxis IDA
IDA: Inferred from direct assay
10410979 RGD
involved in intracellular calcium ion homeostasis IDA
IDA: Inferred from direct assay
10532591 RGD
involved in leukocyte migration involved in inflammatory response IMP
IMP: Inferred from mutant phenotype
10843715 RGD
involved in negative regulation of dopamine secretion IDA
IDA: Inferred from direct assay
18648551 RGD
involved in negative regulation of norepinephrine secretion IDA
IDA: Inferred from direct assay
18648551 RGD
involved in positive regulation of chemotaxis IDA
IDA: Inferred from direct assay
7987212 RGD
involved in positive regulation of cytosolic calcium ion concentration IDA
IDA: Inferred from direct assay
9272704 RGD
Cellular Component GO Annotation Evidence Reference Source
located in extracellular space IDA
IDA: Inferred from direct assay
9246574 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

complement C5

anaphylatoxin

complement component 5

Related Agents

Approval
Bioactive Molecules (10)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-14541 Olanzapine 99.37% Yes
HY-17627 Avacopan Inhibitor 99.75% Yes
HY-147080 Avacincaptad pegol sodium Inhibitor 98.53% Unkown
HY-11100 Asenapine maleate Antagonist 99.95% Unkown
HY-P3502 Zilucoplan Inhibitor 95.33% Unkown
HY-B1213 Trimipramine maleate 99.82% Unkown
HY-16567 Asenapine hydrochloride Antagonist 99.95% Unkown
HY-148457 Avacincaptad pegol Inhibitor / Unkown
HY-14541R Olanzapine (Standard) / Unkown
HY-B1213A Trimipramine / Unkown
Inhibitory Antibodies (5)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99394 Talquetamab 98.52% Unkown
HY-P9914 Eculizumab Inhibitor 97.81% Unkown
HY-P99365 Ravulizumab Inhibitor 95.57% Unkown
HY-P99965 Crovalimab Inhibitor 98.61% Unkown
HY-P99786 Pozelimab Inhibitor 99.42% Unkown
Clinical Phase
Bioactive Molecules (9)
Cat. No. Product Name Effect
Purity Phase
HY-E70206 CpG Methyltransferase / Phase 4
HY-145720 Cemdisiran Inhibitor / Phase 3
HY-101324A MK-212 monohydrochloride Agonist 99.62% Phase 3
HY-101324 MK-212 Agonist / Phase 3
HY-106178 PMX-53 Antagonist 99.98% Phase 2
HY-111200 Vabicaserin hydrochloride Agonist 99.92% Phase 2
HY-101755 Tedatioxetine hydrobromide Antagonist 99.83% Phase 2
HY-19283 DU125530 Antagonist / Phase 2
HY-123044 Tedatioxetine Antagonist / Phase 1
Inhibitory Antibodies (7)
Cat. No. Product Name Effect
Purity Phase
HY-P99520 Vilobelimab Inhibitor 99.27% Phase 3
HY-P99638 Gefurulimab Inhibitor 97.88% Phase 3
HY-P99886 Pexelizumab Inhibitor / Phase 3
HY-P99322 Tesidolumab Inhibitor 97.01% Phase 2
HY-P99450 Avdoralimab Inhibitor 95.16% Phase 2
HY-P99767 Olendalizumab Inhibitor / Phase 2
HY-P990608 Alpitatug / Phase 1
Pre-clinical Phase
Bioactive Molecules (389)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-N0390S1 L-Glutamine-13C5 99.93% Unkown
HY-149652 IRF5-IN-1 Inhibitor 99.91% Unkown
HY-128729 DNA2 inhibitor C5 Inhibitor 98.51% Unkown
HY-138161 JR14a Antagonist 99.59% Unkown
HY-110136A PMX 205 Trifluoroacetate Antagonist 99.50% Unkown
HY-D1612 BODIPY FL C5-Ceramide 99.65% Unkown
HY-103124 DOI hydrochloride Agonist 99.61% Unkown
HY-148141 JPE-1375 Antagonist 99.94% Unkown
HY-W008820 Glutaric acid 98.44% Unkown
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 99.80% Unkown
HY-N0092S2 Inosine-13C5 Agonist 99.90% Unkown
HY-W013636S 2-Ketoglutaric acid-13C5 99.1% Unkown
HY-N0717S6 L-Valine-13C5 99.6% Unkown
HY-N0326S5 L-Methionine-13C5 99.4% Unkown
HY-B0228S1 Adenosine-13C5 99.9% Unkown
HY-128342 Complement C5-IN-1 Inhibitor 99.14% Unkown
HY-126523 N3-C5-NHS ester ≥98.0% Unkown
HY-14608S3 L-Glutamic acid-13C5,15N ≥98.0% Unkown
HY-Y0252S L-Proline-13C5 99.00% Unkown
HY-16992A W-54011 ≥98.0% Unkown
HY-W004710 NH2-C5-NH-Boc 99.88% Unkown
HY-145237 BM213 Agonist 99.81% Unkown
HY-D1610 BODIPY FL C5 99.68% Unkown
HY-132248 C5 Lenalidomide Inhibitor 99.62% Unkown
HY-157080 Dibromomaleimide-C5-COOH 99.30% Unkown
HY-B0445S NAD+-13C5 ammonium 98.89% Unkown
HY-W008820S1 Glutaric acid-d4 ≥99.0% Unkown
HY-110060 NDT 9513727 Antagonist 99.35% Unkown
HY-141840 GLP-1R modulator C5 Modulator 99.60% Unkown
HY-14608S5 L-Glutamic acid-13C5 ≥98.0% Unkown
HY-151667 Biotin-C5-Azide ≥98.0% Unkown
HY-P0014S1 Liraglutide-13C5,15N TFA Agonist 98.19% Unkown
HY-130798 (S,R,S)-AHPC-amido-C5-acid 99.58% Unkown
HY-148671 (S,R,S)-AHPC-amido-C7-acid 98.28% Unkown
HY-N0390S6 L-Glutamine-13C5,15N2 ≥98.0% Unkown
HY-122725B Lenalidomide-C5-NH2 hydrochloride 98.44% Unkown
HY-130703 5-Dehydroepisterol Inhibitor 92.36% Unkown
HY-W006057AS16 Sodium 3-methyl-2-oxobutanoate-13C5 99.00% Unkown
HY-N0717S1 L-Valine-13C5,15N ≥98.0% Unkown
HY-Y0252S4 L-Proline-13C5,15N 99.60% Unkown
HY-Y0520S Itaconic acid-13C5 ≥97.00% Unkown
HY-B1449S10 Uridine-13C5 99.68% Unkown
HY-B1511S Cyclic AMP-13C5 97.45% Unkown
HY-14541S Olanzapine-d3 99.09% Unkown
HY-D1613 BODIPY FL C5-HPC 99.43% Unkown
HY-N0326S6 L-Methionine-13C5,15N 99.20% Unkown
HY-R00540A hsa-miR-30c-5p agomir 96.15% Unkown
HY-RI00540 hsa-miR-30c-5p inhibitor 96.52% Unkown
HY-W010184S 4,6-Dioxoheptanoic acid-13C5 99.8% Unkown
HY-W017018S2 L-Ornithine-1,2,3,4,5-13C5 hydrochloride 99.5% Unkown
HY-W018772S15 D-Ribose(mixture of isomers)-13C5 99.90% Unkown
HY-153785 NH2-C6-ARC186 sodium Inhibitor 92.50% Unkown
HY-130849 (S,R,S)-AHPC-Me-C5-COOH 96.87% Unkown
HY-131889 Thalidomide-O-C5-acid Inducer 95.82% Unkown
HY-136237 Thalidomide-NH-C5-NH2 hydrochloride Inducer 99.28% Unkown
HY-145720A Cemdisiran sodium 96.02% Unkown
HY-130530 AP-C5 98.14% Unkown
HY-137905 Pomalidomide-amido-C5-PEG2-C6-chlorine 99.69% Unkown
HY-138848A Thalidomide-4-O-C5-NH2 hydrochloride Inducer 96.87% Unkown
HY-153098 ARC186 Inhibitor 94.13% Unkown
HY-15543A CP-809101 hydrochloride Agonist 99.37% Unkown
HY-P5506 C5a Receptor agonist, W5Cha Agonist 99.50% Unkown
HY-R00540 hsa-miR-30c-5p mimic 94.48% Unkown
HY-RI00007A hsa-let-7c-5p antagomir 98.47% Unkown
HY-P1033S1 [Pyr1]-Apelin-13, Pro(13C5,15N) TFA 99.85% Unkown
HY-W010256S3 D-Xylulose-13C5 ≥99.0% Unkown
HY-129608 Lenalidomide-acetylene-C5-COOH 99.26% Unkown
HY-113038AS α-Hydroxyglutaric acid-13C5 disodium 99.80% Unkown
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 95.02% Unkown
HY-132141 5-PA-dUTP ≥98.0% Unkown
HY-153098A ARC186 sodium Inhibitor 94.13% Unkown
HY-164088 DBM-C5-VC-PAB-MMAE Inhibitor / Unkown
HY-R00007 hsa-let-7c-5p mimic 91.21% Unkown
HY-R01569 hsa-miR-518c-5p mimic 91.42% Unkown
HY-RI00334 hsa-miR-181c-5p inhibitor 97.20% Unkown
HY-RI00540A hsa-miR-30c-5p antagomir 95.34% Unkown
HY-W096148 Biotin-C4-amide-C5-NH2 ≥97.0% Unkown
HY-B0445S1 NAD+-13C5 98.90% Unkown
HY-N0091S2 Hypoxanthine-13C5 ≥98.0% Unkown
HY-W779017 Thymidine-13C5 Inhibitor 99.90% Unkown
HY-101343 RS 39604 Antagonist ≥98.0% Unkown
HY-108372 Boc-C5-O-C5-O-C6-Cl / Unkown
HY-110136 PMX 205 Antagonist / Unkown
HY-112199 CP-447697 Antagonist 99.70% Unkown
HY-117971 BVT173187 Inhibitor 99.97% Unkown
HY-131455A Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA ≥98.0% Unkown
HY-132856 Lenalidomide-C5-amido-Boc 95.10% Unkown
HY-139336 Pomalidomide-C5-azide 97.46% Unkown
HY-14608S4 L-Glutamic acid-13C5,15N,d5 ≥99.0% Unkown
HY-150918S 5-Methyl-1H-pyrazole-3-propanoic acid-13C5 / Unkown
HY-155672 JPC0323 Modulator 99.5% Unkown
HY-160241 Lenalidomide-C5-acid 96.36% Unkown
HY-16637S3 Folic acid-13C5 ≥95.0% Unkown
HY-N0322S3 Cholesterol-13C5 Agonist 99.5% Unkown
HY-N0390S3 L-Glutamine-13C5,15N2,d5 99.91% Unkown
HY-P4820A SYNV-cyclo(CGGYF) TFA Inhibitor 97.08% Unkown
HY-R00007A hsa-let-7c-5p agomir 99.93% Unkown
HY-W017387S2 Sodium α-ketoisocaproic acid-13C5 99.3% Unkown
HY-113046S 5-Methyltetrahydrofolic acid-13C5 ≥98.0% Unkown
HY-135916 Biotin-C5-amino-C5-amino / Unkown
HY-159064S DSPSAPVNVT(Val-13C5,15N)R TFA 95.00% Unkown
HY-76082S1 L-Pyroglutamic acid-13C5 / Unkown
HY-B1654S Flavin adenine dinucleotide-13C5 ammonium 90.08% Unkown
HY-N0091S Hypoxanthine-13C5,15N4 ≥99.0% Unkown
HY-P10639 C5aR2 agonist P32 Agonist 99.82% Unkown
HY-W028210 O-Phthalimide-C5-acid ≥98.0% Unkown
HY-122725A Lenalidomide-C5-NH2 TFA 98.94% Unkown
HY-141423 Thalidomide-O-amide-C5-NH2 Inducer / Unkown
HY-141423A Thalidomide-O-amide-C5-NH2 TFA Inducer / Unkown
HY-Y1055S4 Guanine-13C5 Chemical / Unkown
HY-136055 (S,R,S)-AHPC-C5-COOH Inhibitor 98.81% Unkown
HY-103120 Org37684 Antagonist / Unkown
HY-10984S3 Pomalidomide-15N,13C5 Inducer / Unkown
HY-112675S 4-Octyl itaconate-13C5-1 / Unkown
HY-113062S 20α-Dihydroprogesterone-13C5 / Unkown
HY-113420S2 11-Dehydro-thromboxane B2-13C5 / Unkown
HY-120498 RS-64459-193 Agonist / Unkown
HY-124117 LY 278584 Antagonist / Unkown
HY-124310 PDE5-IN-6c / Unkown
HY-12956S2 Dinoprost-13C5 / Unkown
HY-130712 NH2-C2-amido-C2-Boc / Unkown
HY-130946 NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 / Unkown
HY-132939 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-C5-Br Chemical / Unkown
HY-134737 Boc-NH-PEG1-C5-OH / Unkown
HY-134986 Thalidomide-NH-C5-NH2 Inducer / Unkown
HY-136187 (S,R,S)-AHPC-C5-NH2 / Unkown
HY-136187A (S,R,S)-AHPC-C5-NH2 dihydrochloride / Unkown
HY-138098 Sartorypyrone B / Unkown
HY-138848 Thalidomide-4-O-C5-NH2 Inducer / Unkown
HY-138851 Thalidomide-NH-amido-C5-NH2 Inducer / Unkown
HY-138851A Thalidomide-NH-amido-C5-NH2 hydrochloride Inducer / Unkown
HY-139996 Pomalidomide-C5-Dovitinib / Unkown
HY-141062 N-Methyl-N'-(azido-PEG2-C5)-Cy5 / Unkown
HY-141143 MC(C5)-Val-Cit / Unkown
HY-141593 Modified MMAF-C5-COOH / Unkown
HY-141902S Fmoc-Glu(OtBu)-OH-13C5,15N ≥96.0% Unkown
HY-14291S2 Vildagliptin-13C5,15N Inhibitor / Unkown
HY-143340 LEB-03-145 / Unkown
HY-144676 pan-HER-IN-1 / Unkown
HY-147585 C5aR-IN-1 / Unkown
HY-147586 C5aR-IN-2 / Unkown
HY-147587 C5aR-IN-3 / Unkown
HY-14781S2 Levomefolic acid-13C5 / Unkown
HY-148326 Glu(OtBu)-Val-Cit-PAB-OH / Unkown
HY-148362 Pomalidomide-C6-O-C5-O-C4-COOH 98.55% Unkown
HY-150632 SARS-CoV-2 nsp13-IN-6 Inhibitor / Unkown
HY-150660S Ercalcidiol-13C5 / Unkown
HY-150661S 3-epi-Calcifediol-13C5 / Unkown
HY-150663S Calcitriol-13C5 / Unkown
HY-153464 CXCR4-IN-1 Inhibitor / Unkown
HY-15398S4 Vitamin D3-13C5 / Unkown
HY-155186 SARS-CoV-2 3CLpro-IN-19 Inhibitor / Unkown
HY-155261 Pomalidomide-5-C5-NH2 hydrochloride / Unkown
HY-155506 NAMPT degrader-3 Degrader / Unkown
HY-157511 Thalidomide-O-C5-azide / Unkown
HY-157933 SF-C5-TPP / Unkown
HY-158627 JPC0323 Oleate Modulator / Unkown
HY-158992S SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT TFA / Unkown
HY-159570 XD2-149 / Unkown
HY-159571 Thalidomide-NH-C5-azacyclohexane-N-Boc / Unkown
HY-159572 NH2-C5-Azacyclohexane-N-Boc / Unkown
HY-160077 Pomalidomide-CO-C5-azide / Unkown
HY-161132 Lenalidomide 4'-alkyl-C5-azide / Unkown
HY-161793 (S,R,S)-AHPC-NHCO-C-O-C5-N3 / Unkown
HY-161939 7030B-C5 Inhibitor / Unkown
HY-162950 Piperidin-4-amine-C5-O-C1-Thalidomide / Unkown
HY-163378 C5aR1 antagonist 1 Antagonist / Unkown
HY-163379 C5aR1 antagonist 2 Antagonist / Unkown
HY-163788 C5-CONH-C2-N-CH3 / Unkown
HY-16384 L-156602 Antagonist / Unkown
HY-164084 DBCO-NHCO-C5-O-phenylethenesulfonyl fluoride / Unkown
HY-164829 Mal-C5-Gly-Gly-Phe-MMAE Inhibitor / Unkown
HY-16567S Asenapine-13C,d3 hydrochloride Antagonist / Unkown
HY-16637S2 (Rac)-Folic acid-13C5,15N / Unkown
HY-16637S4 Folic acid-13C5,15N / Unkown
HY-168039 Boc-NH-Piperidine-C5-OH / Unkown
HY-168040 Thalidomide-O-C5-piperidine-NH-Boc / Unkown
HY-168175 PROTAC HDAC8 Degrader-2 Degrader / Unkown
HY-169010 Pomalidomide-CO-C5-Br / Unkown
HY-170820 XYD049 / Unkown
HY-172213 (3S,6R)-NML Antagonist / Unkown
HY-173010 Me-(S,R,S)-AHPC-CO-C5-N3 / Unkown
HY-17383S Levomefolate-13C5 calcium Chemical / Unkown
HY-18252S1 Avanafil-13C5,15N,d2 / Unkown
HY-19528S1 SAH-13C5 / Unkown
HY-21994 Org-12962 hydrochloride Agonist / Unkown
HY-32351AS1 Calcifediol-13C5 monohydrate / Unkown
HY-A0003S2 Lenalidomide-13C5,15N Inducer / Unkown
HY-B0152S2 Adenine-13C5,15N5 Chemical / Unkown
HY-B0389S17 D-Glucose-13C-5 / Unkown
HY-B0434S Ribavirin-13C5 Inhibitor / Unkown
HY-B0456S2 Riboflavin-13C5 / Unkown
HY-D1592 BODIPY TMR C5-maleimide / Unkown
HY-D1611 BODIPY FL-C5 NHS Ester / Unkown
HY-I1111S2 Fmoc-L-Val-OH-13C5,15N Inhibitor ≥98% Unkown
HY-I1111S3 Fmoc-L-Val-OH-13C5 / Unkown
HY-N0210S4 D-Galactose-13C-5 / Unkown
HY-N0379S10 D-Mannose-13C-5 / Unkown
HY-N0437S1 Progesterone-13C5 Agonist / Unkown
HY-N0717S2 L-Valine-13C5,15N,d8 / Unkown
HY-N0717S3 L-Valine-13C5,15N,d2 / Unkown
HY-N12728 Heteroclitin G / Unkown
HY-N13081 3-Oxo-cinobufagin / Unkown
HY-N3406 Lansiumarin C / Unkown
HY-N7082S D-​Arabinose-13C5 Inhibitor / Unkown
HY-P10274 CM05 Inhibitor / Unkown
HY-P10653 C5A Inhibitor / Unkown
HY-P3502A Zilucoplan TFA Inhibitor / Unkown
HY-P4820 SYNV-cyclo(CGGYF) Inhibitor / Unkown
HY-P4971 C5a Anaphylatoxin (human) Modulator / Unkown
HY-R00334 hsa-miR-181c-5p mimic / Unkown
HY-R00334A hsa-miR-181c-5p agomir / Unkown
HY-R00408 hsa-miR-200c-5p mimic / Unkown
HY-R00408A hsa-miR-200c-5p agomir / Unkown
HY-R00514 hsa-miR-29c-5p mimic / Unkown
HY-R00514A hsa-miR-29c-5p agomir / Unkown
HY-R00718 hsa-miR-34c-5p mimic / Unkown
HY-R00718A hsa-miR-34c-5p agomir / Unkown
HY-R00833 hsa-miR-374c-5p mimic / Unkown
HY-R00833A hsa-miR-374c-5p agomir / Unkown
HY-R00841 hsa-miR-376c-5p mimic / Unkown
HY-R00841A hsa-miR-376c-5p agomir / Unkown
HY-R01113 hsa-miR-449c-5p mimic / Unkown
HY-R01113A hsa-miR-449c-5p agomir / Unkown
HY-R01547 hsa-miR-513c-5p mimic / Unkown
HY-R01547A hsa-miR-513c-5p agomir / Unkown
HY-R01569A hsa-miR-518c-5p agomir / Unkown
HY-R02507 hsa-miR-892c-5p mimic / Unkown
HY-R02507A hsa-miR-892c-5p agomir / Unkown
HY-R02796 mmu-miR-1970c-5p mimic / Unkown
HY-R02796A mmu-miR-1970c-5p agomir / Unkown
HY-R02834 mmu-miR-216c-5p mimic / Unkown
HY-R02834A mmu-miR-216c-5p agomir / Unkown
HY-R02841 mmu-miR-219c-5p mimic / Unkown
HY-R02841A mmu-miR-219c-5p agomir / Unkown
HY-R02883 mmu-miR-297c-5p mimic / Unkown
HY-R02883A mmu-miR-297c-5p agomir / Unkown
HY-R02898 mmu-miR-302c-5p mimic / Unkown
HY-R02898A mmu-miR-302c-5p agomir / Unkown
HY-R03044 mmu-miR-344c-5p mimic / Unkown
HY-R03044A mmu-miR-344c-5p agomir / Unkown
HY-R03105 mmu-miR-374c-5p mimic / Unkown
HY-R03105A mmu-miR-374c-5p agomir / Unkown
HY-R03112 mmu-miR-376c-5p mimic / Unkown
HY-R03112A mmu-miR-376c-5p agomir / Unkown
HY-R03149 mmu-miR-449c-5p mimic / Unkown
HY-R03149A mmu-miR-449c-5p agomir / Unkown
HY-R03164 mmu-miR-465c-5p mimic / Unkown
HY-R03164A mmu-miR-465c-5p agomir / Unkown
HY-R03171 mmu-miR-466c-5p mimic / Unkown
HY-R03171A mmu-miR-466c-5p agomir / Unkown
HY-R03199 mmu-miR-467c-5p mimic / Unkown
HY-R03199A mmu-miR-467c-5p agomir / Unkown
HY-R03461 mmu-miR-669c-5p mimic / Unkown
HY-R03461A mmu-miR-669c-5p agomir / Unkown
HY-R04278 rno-miR-196c-5p mimic / Unkown
HY-R04278A rno-miR-196c-5p agomir / Unkown
HY-R04285 rno-miR-200c-5p mimic / Unkown
HY-R04285A rno-miR-200c-5p agomir / Unkown
HY-R04448 rno-miR-376c-5p mimic / Unkown
HY-R04448A rno-miR-376c-5p agomir / Unkown
HY-R04485 rno-miR-466c-5p mimic / Unkown
HY-R04485A rno-miR-466c-5p agomir / Unkown
HY-RI00007 hsa-let-7c-5p inhibitor / Unkown
HY-RI00334A hsa-miR-181c-5p antagomir / Unkown
HY-RI00408 hsa-miR-200c-5p inhibitor / Unkown
HY-RI00408A hsa-miR-200c-5p antagomir / Unkown
HY-RI00514 hsa-miR-29c-5p inhibitor / Unkown
HY-RI00514A hsa-miR-29c-5p antagomir / Unkown
HY-RI00718 hsa-miR-34c-5p inhibitor / Unkown
HY-RI00718A hsa-miR-34c-5p antagomir / Unkown
HY-RI00833 hsa-miR-374c-5p inhibitor / Unkown
HY-RI00833A hsa-miR-374c-5p antagomir / Unkown
HY-RI00841 hsa-miR-376c-5p inhibitor / Unkown
HY-RI00841A hsa-miR-376c-5p antagomir / Unkown
HY-RI01113 hsa-miR-449c-5p inhibitor / Unkown
HY-RI01113A hsa-miR-449c-5p antagomir / Unkown
HY-RI01547 hsa-miR-513c-5p inhibitor / Unkown
HY-RI01547A hsa-miR-513c-5p antagomir / Unkown
HY-RI01569 hsa-miR-518c-5p inhibitor / Unkown
HY-RI01569A hsa-miR-518c-5p antagomir / Unkown
HY-RI02507 hsa-miR-892c-5p inhibitor / Unkown
HY-RI02507A hsa-miR-892c-5p antagomir / Unkown
HY-RI02796 mmu-miR-1970c-5p inhibitor / Unkown
HY-RI02796A mmu-miR-1970c-5p antagomir / Unkown
HY-RI02834 mmu-miR-216c-5p inhibitor / Unkown
HY-RI02834A mmu-miR-216c-5p antagomir / Unkown
HY-RI02841 mmu-miR-219c-5p inhibitor / Unkown
HY-RI02841A mmu-miR-219c-5p antagomir / Unkown
HY-RI02883 mmu-miR-297c-5p inhibitor / Unkown
HY-RI02883A mmu-miR-297c-5p antagomir / Unkown
HY-RI02898 mmu-miR-302c-5p inhibitor / Unkown
HY-RI02898A mmu-miR-302c-5p antagomir / Unkown
HY-RI03044 mmu-miR-344c-5p inhibitor / Unkown
HY-RI03044A mmu-miR-344c-5p antagomir / Unkown
HY-RI03105 mmu-miR-374c-5p inhibitor / Unkown
HY-RI03105A mmu-miR-374c-5p antagomir / Unkown
HY-RI03112 mmu-miR-376c-5p inhibitor / Unkown
HY-RI03112A mmu-miR-376c-5p antagomir / Unkown
HY-RI03149 mmu-miR-449c-5p inhibitor / Unkown
HY-RI03149A mmu-miR-449c-5p antagomir / Unkown
HY-RI03164 mmu-miR-465c-5p inhibitor / Unkown
HY-RI03164A mmu-miR-465c-5p antagomir / Unkown
HY-RI03171 mmu-miR-466c-5p inhibitor / Unkown
HY-RI03171A mmu-miR-466c-5p antagomir / Unkown
HY-RI03199 mmu-miR-467c-5p inhibitor / Unkown
HY-RI03199A mmu-miR-467c-5p antagomir / Unkown
HY-RI03461 mmu-miR-669c-5p inhibitor / Unkown
HY-RI03461A mmu-miR-669c-5p antagomir / Unkown
HY-RI04278 rno-miR-196c-5p inhibitor / Unkown
HY-RI04278A rno-miR-196c-5p antagomir / Unkown
HY-RI04285 rno-miR-200c-5p inhibitor / Unkown
HY-RI04285A rno-miR-200c-5p antagomir / Unkown
HY-RI04448 rno-miR-376c-5p inhibitor / Unkown
HY-RI04448A rno-miR-376c-5p antagomir / Unkown
HY-RI04485 rno-miR-466c-5p inhibitor / Unkown
HY-RI04485A rno-miR-466c-5p antagomir / Unkown
HY-RS01749 C5 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01750 C5AR1 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01751 C5AR2 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS12597 SDR16C5 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-W000450S 5-Aminolevulinic acid-13C / Unkown
HY-W008371S1 Fmoc-Met-OH-13C5,15N / Unkown
HY-W008585 Benzo-15-crown-5-ether 99.02% Unkown
HY-W008820S2 Glutaric acid-d2 / Unkown
HY-W009538S1 5-Fluoro-5'-deoxycytidine-13C5 / Unkown
HY-W013780S1 Fmoc-Pro-OH-13C5,15N Inhibitor / Unkown
HY-W015913S4 2-Oxopropanoate-13c2 sodium / Unkown
HY-W016145S L-Glutamic acid-13C5 hydrate salt / Unkown
HY-W017401S Benzisothiazolinone-13C5 Inhibitor / Unkown
HY-W040047S Pregnanediol 3-glucuronide-13C5 / Unkown
HY-W040055S Neopterin-13C5 / Unkown
HY-W096134 Benzyloxy-C5-PEG1 / Unkown
HY-W400722 Sodium 3-methyl-2-oxobutanoate-13C5,d1 / Unkown
HY-W777286 rac-Lenalidomide-13C5 / Unkown
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) 96.25% Unkown
HY-Y0252S6 L-Proline-13C5,15N,d7 / Unkown
HY-Y1055S2 Guanine-13C5,15N5 Chemical / Unkown
HY-106178D PMX 53 monoacetate / Unkown
HY-106400 EGIS 11150 Antagonist / Unkown
HY-113209S2 8-Isoprostaglandin F2α-13C5 / Unkown
HY-113266S Valerylcarnitine-d9 / Unkown
HY-117872 Sartorypyrone A / Unkown
HY-133411A NH2-O-C5-COOH hydrobromide / Unkown
HY-143704S 5-Aminosalicylic acid-13C6 hydrochloride 99.53% Unkown
HY-144345S L-γ-Glutamyl-L-cysteinyl-L-lysine-13C5,15N / Unkown
HY-14541A Olanzapine hydrochloride / Unkown
HY-14541S2 Olanzapine-d8 / Unkown
HY-147338S1 5-Methylcytidine 5′-triphosphate-15N2,13C trisodium / Unkown
HY-14879S2 Avibactam sodium salt-13C5 Inhibitor / Unkown
HY-149562 Thalidomide-5-O-C5-NH2 hydrochloride / Unkown
HY-149691 O-Phthalimide-C1-S-C5-acid / Unkown
HY-149751 Methylthiomcresol-C5-COOH / Unkown
HY-15401A WAY 163909 hydrochloride / Unkown
HY-15543 CP-809101 Agonist / Unkown
HY-158382 NH2-C4-PEG4-C5-COOH / Unkown
HY-159046S ASGITFSNSGMHW(Val-13C5,15N)R TFA / Unkown
HY-159065S FIQE(Val-13C5,15N)NTTTR TFA / Unkown
HY-160235 Pomalidomide-C2-amide-C5-azide / Unkown
HY-160901 CP-289,503 Inhibitor / Unkown
HY-161792 N3-C5-O-C-Boc / Unkown
HY-162948 (S,R,S)-AHPC-PEG2-C5-N3 / Unkown
HY-162949 Piperidin-4-amine-C5-O-C1 / Unkown
HY-170796 α-Amylase-IN-11 Inhibitor / Unkown
HY-173102S LQEEIDAVL(Pro-13C5,15N)NK TFA / Unkown
HY-173105S TPEEAHALSA(Pro-13C5,15N)TSR TFA / Unkown
HY-50719S1 2-Acetyl-1-pyrroline-13C5 / Unkown
HY-B0152S3 Adenine-13C5 Chemical / Unkown
HY-B0660S1 Eicosapentaenoic acid 1,2,3,4,5-13C5 Activator / Unkown
HY-B1204S2 Histamine-13C5, 15N3 Activator / Unkown
HY-B1204S3 Histamine-13C5 / Unkown
HY-B2130S2 Uric acid-13C5 / Unkown
HY-N13147 Tetromycin C5 Inhibitor / Unkown
HY-P10639A C5aR2 agonist P32 acetate Agonist / Unkown
HY-P3502B Zilucoplan (PEG2) Inhibitor / Unkown
HY-W010450S5 Thymine-13C5,15N2 / Unkown
HY-W011297S3 Methyl arachidonate-13C5 / Unkown
HY-W039426 N-Trityl-N4-benzoyl-morpholino-C-5'-O-phosphoramidite / Unkown
HY-W130878 4-Octylphenol Activator / Unkown
HY-W251144 N,N′-Dipentyl-3,4,9,10-perylenedicarboximide / Unkown
HY-W338810S S-(5'-Adenosyl)-L-methionine-13C5 sulfate / Unkown
HY-W654041 Adenosine monophosphate-13C5 / Unkown
HY-W728005 Covidcil-19 Inhibitor / Unkown
HY-W778183 3,5,6-Trichloro-2-pyridinol-13C5 / Unkown
HY-W778207 2'-Deoxyadenosine-13C5 monohydrate / Unkown
HY-W779015 5-Methyluridine-13C5 / Unkown
HY-W779800 D-α-Hydroxyglutaric acid-13C5 disodium / Unkown
HY-W814363 Octadec-9-enoic acid-13C5 / Unkown
HY-W838632 Antibacterial agent 266 Inhibitor / Unkown
Inhibitory Antibodies (4)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P990998 Greziprubart Inhibitor / Unkown
HY-P990745 Izastobart Ligand / Unkown
HY-P990753 Omoprubart / Unkown
HY-P991067 Vensobafusp alfa Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens C5 NCBI NCBI:727
Macaca fascicularis C5 NCBI NCBI:102125658
Mus musculus C5 NCBI
Susscrofa domestica C5 NCBI
Macaca mulatta C5 NCBI NCBI:700467